UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.03 Million Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its position in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 25.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 45,649 shares of the company’s stock after selling 15,608 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.11% of Phibro Animal Health worth $1,028,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in PAHC. Sofinnova Investments Inc. acquired a new stake in Phibro Animal Health in the 2nd quarter valued at $3,975,000. American Century Companies Inc. boosted its position in Phibro Animal Health by 119.6% during the second quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock valued at $5,822,000 after purchasing an additional 189,068 shares during the last quarter. Dana Investment Advisors Inc. boosted its position in Phibro Animal Health by 17.2% during the second quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company’s stock valued at $8,619,000 after purchasing an additional 75,546 shares during the last quarter. Algert Global LLC grew its stake in Phibro Animal Health by 521.1% in the third quarter. Algert Global LLC now owns 71,335 shares of the company’s stock valued at $1,606,000 after purchasing an additional 59,850 shares in the last quarter. Finally, AXA S.A. acquired a new position in shares of Phibro Animal Health during the 2nd quarter worth approximately $906,000. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Stock Down 4.8 %

Phibro Animal Health stock opened at $21.27 on Thursday. The company’s 50-day moving average price is $23.63 and its two-hundred day moving average price is $20.66. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. The stock has a market cap of $861.50 million, a P/E ratio of 49.47, a P/E/G ratio of 0.58 and a beta of 0.51. Phibro Animal Health Co. has a twelve month low of $10.03 and a twelve month high of $25.98.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th were paid a dividend of $0.12 per share. The ex-dividend date was Wednesday, November 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.26%. Phibro Animal Health’s dividend payout ratio (DPR) is currently 111.63%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Barclays raised their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research note on Tuesday, November 12th. Morgan Stanley raised their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday. Bank of America boosted their price target on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th. StockNews.com upgraded Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research note on Wednesday. Finally, JPMorgan Chase & Co. initiated coverage on Phibro Animal Health in a research note on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $20.50.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.